Joinhub Pharma Llp

Joinhub Pharma Llp - pharma in Ahmadabad City, Gujarat, India. FY 2026 financials and compliance.
LLPIN AAS-0259 Incorporated 24 February 2020 ROC Ahmedabad HQ Ahmadabad City, Gujarat, India
Active Limited Liability Partnership pharma
Data last updated
Revenue · FY 2023
₹12.59 Cr
▲ 117.74% YoY
EBITDA · FY 2023
*****
▲ 217.56% YoY
Net profit · FY 2023
*****
▲ 456.69% YoY
Contribution obligation
₹10,000
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
₹60.63 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Last financials
Mar 2025
Balance sheet date

About Joinhub Pharma Llp

Data last updated: 16 February 2026

Joinhub Pharma Llp is a limited liability partnership company based in Ahmadabad City, Gujarat, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 24 February 2020, the LLP has been in operation for over 6 years.

Registered with ROC Ahmedabad under LLPIN AAS-0259.

Capital: a total obligation of contribution of ₹10,000. It is led by designated partners including Abbasali Mahammadali Balospura and Ahemadabbas Gulamhaidar Balospura.

Accounts filed on 31 March 2025. Office: Ahmadabad City, Gujarat.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹12.59 Cr, a growth of 117.74% compared to the previous year.

As per MCA filings, the LLP has open charges of ₹60.63 Cr on record.

Company Details of Joinhub Pharma Llp
LLPIN AAS-0259
Incorporation Date 24 February 2020
Total Obligation of Contribution ₹10,000
ROC Ahmedabad
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Abbasali Mahammadali Balospura Designated Partner Ahemadabbas Gulamhaidar Balospura Partner Aabid Ali Designated Partner
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    A – 502 5Th Floor, Mondeal Heights, Ahmadabad City, Gujarat, India – 380051
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Joinhub Pharma Llp - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Joinhub Pharma Llp report

Financials, compliance, directors, charges, ownership and filings for Joinhub Pharma Llp in one report.

10-year financials Directors & ownership Charges & compliance

Designated Partners of Joinhub Pharma Llp

Joinhub Pharma Llp is currently managed by 3 designated partners, with 1 former designated partner having served the organization. The current Designated Partners play a crucial role in shaping the company's strategic direction and governance.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Abbasali Mahammadali Balospura
Also directs: Joinhub Global Exports Llp, Aliyan Pharmaceuticals Llp, Pyxus Pharmaceuticals Private Limited and 1 more
Designated Partner 19 Jan 2021 5 Years 5 Months Current
Ahemadabbas Gulamhaidar Balospura
Also directs: Joinhub Global Exports Llp, Aliyan Pharmaceuticals Llp, Gutsalve Lifesciences Private Limited and 4 more
Partner 13 Sep 2021 4 Years 9 Months Current
Aabid Ali
Also directs: Aliyan Pharmaceuticals Llp, Pyxus Pharmaceuticals Private Limited, Emed Healthtech Private Limited and 2 more
Designated Partner 02 Dec 2025 0 Years 7 Months Current
View all designated partners

Financials of Joinhub Pharma Llp FY 2025 filings available

Joinhub Pharma Llp reported revenue of ₹12.48 Cr (up 117.74% YoY) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹12.48 Cr ▲ 117.74%
Profit
***** ▲ 456.69%
EBITDA
***** ▲ 217.56%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****
Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF
What Is the Ownership and Shareholding Structure of Joinhub Pharma Llp?

View Joinhub Pharma Llp's control and ownership data: shareholding patterns, funding details, FII information, directors and KMP remuneration, group structure, overseas investment and related data.

Shareholding Pattern (FY 2026)
Shareholding pattern chart
  • Promoters: **.**%
  • Public: **.**%
  • Others: **.**%
Shareholding Pattern over the Year
FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Promoters**.****.****.****.****.**
Public**.****.****.****.****.**
Others**.****.****.****.****.**

Full shareholding pattern with quarterly trends.

Charges & Borrowings of Joinhub Pharma Llp

Open charges
₹60.63 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Saraswat Co Operative Bank Ltd₹59.96 Cr
Saraswat Co Operative Bank Ltd Naranpura Branch₹0.67 Cr
Latest charge details
DateLenderAmountStatus
22 Sep 2023 Saraswat Co Operative Bank Ltd ₹29.98 Cr Open
21 Sep 2023 Saraswat Co Operative Bank Ltd Naranpura Branch ₹67 Lakh Open
20 Sep 2023 Saraswat Co Operative Bank Ltd ₹29.98 Cr Open

Total charge records: 3 View all charges

Employees and EPFO Compliance at Joinhub Pharma Llp

View historical data on people associated with Joinhub Pharma Llp, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Joinhub Pharma Llp

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Joinhub Pharma Llp

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Joinhub Pharma Llp

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Joinhub Pharma Llp

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Joinhub Pharma Llp

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Joinhub Pharma Llp

MSME Payment Delays by Joinhub Pharma Llp

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Joinhub Pharma Llp

Subsidiaries & Group Companies of Joinhub Pharma Llp

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Joinhub Pharma Llp with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Joinhub Pharma Llp

MCA Filings & Documents of Joinhub Pharma Llp

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Joinhub Pharma Llp

Directors
02 Dec 2025
Aabid Ali was appointed as a Designated Partner on 02 Dec 2025 & has been associated with this company since 7 months 7 days.
Activity
31 Mar 2025
Joinhub Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Activity
31 Mar 2025
Joinhub Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
04 Dec 2024
A charge with Saraswat Co Operative Bank Ltd of Rs. 299,800,000.00 registered on 20 Sep 2023 with Charge ID 100795443 was modified on 04 Dec 2024.
Charges
25 Sep 2024
A charge with Saraswat Co Operative Bank Ltd of Rs. 299,800,000.00 registered on 22 Sep 2023 with Charge ID 100795439 was modified on 25 Sep 2024.
Charges
22 Sep 2023
A charge with Saraswat Co Operative Bank Ltd amounted to Rs. 299,800,000.00 with Charge ID 100795439 was registered on 22 Sep 2023.

Frequently Asked Questions about Joinhub Pharma Llp

Joinhub Pharma Llp is an active limited liability partnership in the pharma sector based in Ahmadabad City, Gujarat, India. It was incorporated on 24 February 2020 (6+ years old) and is registered under LLPIN AAS-0259.

Joinhub Pharma Llp reported revenue of ₹12.59 Cr for FY 2023 (up 117.74% YoY).

The current designated partners of Joinhub Pharma Llp are:

The primary industry of Joinhub Pharma Llp is pharma. The LLP specifically operates in pharmaceutical retailers and distributors. The LLP is currently active in this sector.

Joinhub Pharma Llp can be reached at the registered office: A – 502 5Th Floor, Mondeal Heights, Ahmadabad City, Gujarat, India – 380051.

The total obligation of contribution is ₹10,000.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available